ESTRO 2024 - Abstract Book

S824

Clinical - CNS

ESTRO 2024

No patient experienced acute radiation-induced toxicity CTCAE grade 3 or higher. However, 73 (82.0%) of patients developed grade 1 or 2 acute toxicity, while 16 (18.0%) experienced no acute toxicity. Only 2 (2.2%) and 1 (1.1%) patients presented with grade 4 and 3 late radiation-induced toxicity, respectively. No grade 5 late adverse event was observed.

Of 44 eligible patients, 42 (95.5%) participated in the longitudinal QoL study. The global health as a domain of QoL remained stable and comparable to the reference values [1] during PBS-PT and for six years thereafter.

Of 66 eligible patients, 14 (21.2%) participated in our cross-sectional SH study. Our findings suggest comparable values for many SH scores between the current study and reference values from the validation study [2]. For sexual satisfaction, we observed a mean score of 44.86 (±22.77 SD), compared to a mean score of 42.80 (±26.39 SD) in the reference population.

Conclusion: